Logo image of VHNA

VAHANNA TECH EDGE ACQUISI-A (VHNA) Stock Fundamental Analysis

NASDAQ:VHNA - Nasdaq - VGG9320Z1099 - Common Stock - Currency: USD

11.12  +0.91 (+8.91%)

After market: 10.88 -0.24 (-2.16%)

Fundamental Rating

1

Taking everything into account, VHNA scores 1 out of 10 in our fundamental rating. VHNA was compared to 0 industry peers in the Unkown industry. VHNA may be in some trouble as it scores bad on both profitability and health. VHNA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

VHNA had positive earnings in the past year.
In the past year VHNA has reported a negative cash flow from operations.
VHNA Yearly Net Income VS EBIT VS OCF VS FCFVHNA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 0 500K -500K -1M -1.5M

1.2 Ratios

Industry RankSector Rank
ROA 0.63%
ROE 0.68%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VHNA Yearly ROA, ROE, ROICVHNA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 0 0.2 -0.2 0.4 -0.4 -0.6

1.3 Margins

VHNA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VHNA Yearly Profit, Operating, Gross MarginsVHNA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, VHNA has more shares outstanding
VHNA has a worse debt/assets ratio than last year.
VHNA Yearly Shares OutstandingVHNA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 5M 10M 15M 20M 25M
VHNA Yearly Total Debt VS Total AssetsVHNA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 50M 100M 150M 200M

2.2 Solvency

An Altman-Z score of 11.99 indicates that VHNA is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.01 indicates that VHNA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 11.99
ROIC/WACCN/A
WACCN/A
VHNA Yearly LT Debt VS Equity VS FCFVHNA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 0 50M 100M 150M

2.3 Liquidity

VHNA has a Current Ratio of 0.03. This is a bad value and indicates that VHNA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.03 indicates that VHNA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.03
Quick Ratio 0.03
VHNA Yearly Current Assets VS Current LiabilitesVHNA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 500K 1M

More info and screens

1

3. Growth

3.1 Past

VHNA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 173.80%, which is quite impressive.
EPS 1Y (TTM)173.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.69%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 222.40, the valuation of VHNA can be described as expensive.
The average S&P500 Price/Earnings ratio is at 26.34. VHNA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 222.4
Fwd PE N/A
VHNA Price Earnings VS Forward Price EarningsVHNA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VHNA Per share dataVHNA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

VHNA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VAHANNA TECH EDGE ACQUISI-A

NASDAQ:VHNA (9/20/2023, 8:06:45 PM)

After market: 10.88 -0.24 (-2.16%)

11.12

+0.91 (+8.91%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap278.14M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 222.4
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.39
P/tB 1.39
EV/EBITDA N/A
EPS(TTM)0.05
EY0.45%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0
BVpS7.97
TBVpS7.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.63%
ROE 0.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.03
Quick Ratio 0.03
Altman-Z 11.99
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%128.69%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-674.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2275.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2275.81%
OCF growth 3YN/A
OCF growth 5YN/A